Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Annual Review of Medicine|January 29, 2024
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate CancerLena M Unterrainer, Jeremie Calais, Neil H Bander
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate CancerLena M Unterrainer, Honest Ndlovu, Thomas A Hope, et al.
Clinical Nuclear Medicine|August 16, 2023
Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99m Tc-DPD ScintigraphySophie C Kunte, Stéphanie K Schwarting, Adrien Holzgreve, et al.
Radiologie (Heidelberg, Germany)|October 20, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Siegmund, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Urologie (Heidelberg, Germany)|August 18, 2025
[Options in nuclear medicine for advanced prostate cancer in practice]Sophie Carina Kunte, Philipp M Kazmierczak, Adrien Holzgreve, et al.
Cancers|April 27, 2024
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the BladderAlexander Tamalunas, Can Aydogdu, Lena M Unterrainer, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
Finger Pain as an Uncommon Primary Manifestation of Lung CarcinomaAdrien Holzgreve, Hans Roland Dürr, Axel Stäbler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 TherapyJulia Brosch-Lenz, Astrid Delker, Friederike Völter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Cost-Effectiveness of [<sup>177</sup>Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 TrialAdrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2024
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&T TherapySandra Resch, Sibylle I Ziegler, Gabriel Sheikh, et al.
Pageof 7